Aminah Alotaibi | Breast Cancer | Best Researcher Award

Published on by Oncology

Dr. Aminah Alotaibi | Breast Cancer | Best Researcher Award

Assistant Research Professor | King Abdulaziz city for science and technology | Saudi Arabia

Dr. Aminah Ghazi Alotaibi is a distinguished researcher affiliated with the King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia. With a Scopus h-index of 3, 4 indexed publications, and 58 citations, she has demonstrated consistent scholarly impact in the fields of hematology, stem cell biology, and molecular diagnostics. Her research primarily focuses on elucidating the phenotypic and molecular diversity of hematopoietic stem and progenitor cells (HSPCs) derived from cord blood and bone marrow, advancing the understanding of their biological significance and translational potential in clinical applications. Notably, her recent open-access article titled “Distinct Phenotypic and Molecular Characteristics of CD34− and CD34+ Hematopoietic Stem/Progenitor Cell Subsets in Cord Blood and Bone Marrow Samples: Implications for Clinical Applications” (2025, Diagnostics) highlights her expertise in cellular characterization and regenerative medicine, offering valuable insights for stem cell-based therapies and transplantation science. Dr. Alotaibi’s collaborative network spans 23 co-authors, reflecting her active engagement in multidisciplinary and international scientific research. Her work integrates clinical hematology, genomics, and translational biomedical research, bridging the gap between laboratory discoveries and patient-centered innovations. Through her contributions, she aims to enhance diagnostic precision, therapeutic efficacy, and personalized medical approaches in hematologic and immune-related disorders. Dr. Alotaibi’s scholarly endeavors not only strengthen Saudi Arabia’s presence in global biomedical research but also contribute to the broader scientific community’s understanding of stem cell biology and its clinical potential.

Profiles: Google Scholar | Scopus | ORCID | LinkedIn

Featured Publications

1. Alotaibi, A. G., Li, J. V., & Gooderham, N. J. (2021). Tumour necrosis factor-α (TNF-α) enhances dietary carcinogen-induced DNA damage in colorectal cancer epithelial cells through activation of JNK signaling pathway. Toxicology, 457, 152806. Cited by: 36

2. Al-Saleh, I., Elkhatib, R., Al-Rajoudi, T., Al-Qudaihi, G., Manogarannogaran, P., Alotaibi, A. G., & others. (2020). Cytotoxic and genotoxic effects of e-liquids and their potential associations with nicotine, menthol and phthalate esters. Chemosphere, 249, 126153. Cited by: 22

3. Alotaibi, A. G., Li, J. V., & Gooderham, N. J. (2023). Tumour necrosis factor-alpha (TNF-α)-induced metastatic phenotype in colorectal cancer epithelial cells: Mechanistic support for the role of microRNA-21. Cancers, 15(3), 627. Cited by: 21

4. Gaafar, A., Hamza, F. N., Yousif, R., Shinwari, Z., Alotaibi, A. G., Iqniebi, A., & others. (2025). Distinct phenotypic and molecular characteristics of CD34− and CD34+ hematopoietic stem/progenitor cell subsets in cord blood and bone marrow samples: Implications for clinical applications. Diagnostics, 15(4), 447. Cited by: 1

5. Alotaibi, A. G. (2023). Effect of the inflammatory mediator TNF-α on colorectal cancer epithelial cells development and metastasis, role of dietary carcinogens and miRNA [Doctoral dissertation, Imperial College London]. Imperial College Repository.

Dr. Aminah Ghazi Alotaibi’s research advances global understanding of inflammation-driven carcinogenesis and stem cell biology, bridging molecular insights with clinical translation. Her work contributes to precision oncology, regenerative medicine, and the development of safer therapeutic strategies, fostering innovation that benefits both scientific progress and human health worldwide.

Ramon Mangues | Cancer | Best Research Article Award

Published on by Oncology

Prof. Dr. Ramon Mangues | Cancer | Best Research Article Award

Pharmacological Research | Institut de Recerca Sant Pau | Spain

Prof. Dr. Ramon Mangues Bafalluy, PharmD, PhD, is a distinguished Clinical Pharmacist and Biomedical Research Professor at the Institut de Recerca, Hospital de la Santa Creu i Sant Pau, where he leads the Consolidated Oncogenesis and Antitumor Drugs Group (GOA). A recognized authority in oncology, nanomedicine, and targeted drug delivery, he has made pioneering contributions to the development of therapeutic nanotechnologies and translational cancer research. Trained in pharmacy and clinical pharmacology, Dr. Mangues advanced his expertise in cancer biology through extensive postdoctoral research at the New York University Medical Center. His professional career spans key leadership roles within IIB Sant Pau, CIBER-BBN, and as Co-founder and Scientific Advisor of Nanoligent S.L., a spin-off dedicated to translating nanomedicine discoveries into clinical therapies. His research interests encompass nanoconjugates, protein-based nanoparticles for targeted drug delivery, immunotherapeutic strategies, preclinical drug development, and biomarker identification for improved cancer diagnosis and treatment. A strong advocate of collaborative science, he has partnered with leading clinical specialists and secured numerous competitive research grants, including participation in major European Union initiatives such as SAFE-N-MEDTECH, EuroTransBio, and H2020 programs. Holding multiple patents in nanomedicine, Dr. Mangues’s innovative work bridges the gap between molecular oncology and clinical application. As a mentor and academic leader, he has supervised numerous doctoral theses and authored an extensive body of publications that have shaped contemporary cancer nanotherapy approaches. His achievements have been recognized through prestigious distinctions for research excellence and international scientific leadership. Dr. Mangues’s enduring impact on biomedical innovation is evident through 7,280 citations, 154 documents, and an h-index of 42, underscoring his influential role in advancing nanomedicine and targeted cancer therapy research.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Merlos-Suárez, A., Barriga, F. M., Jung, P., Iglesias, M., Céspedes, M. V., Rossell, D., Sevillano, M., Attolini, C. S.-O., Hernando-Momblona, X., da Silva-Diz, V., Muñoz, P., Clevers, H., Sancho, E., Mangues, R., & Batlle, E. (2011). The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell, 8(5), 511–524. Cited by: 1,145

2. Sanchez-Garcia, L., Martín, L., Mangues, R., Ferrer-Miralles, N., Vázquez, E., & Villaverde, A. (2016). Recombinant pharmaceuticals from microbial cells: A 2015 update. Microbial Cell Factories, 15(1), 33. Cited by: 445

3. Esteller, M., Gonzalez, S., Risques, R. A., Marcuello, E., Mangues, R., Germa, J. R., Herman, J. G., Capellà, G., & Peinado, M. A. (2001). K-ras and p16 aberrations confer poor prognosis in human colorectal cancer. Journal of Clinical Oncology, 19(2), 299–304. Cited by: 335

4. Guerrero, S., Casanova, I., Farré, L., Mazo, A., Capellà, G., & Mangues, R. (2000). K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene. Cancer Research, 60(23), 6750–6756. Cited by: 325

5. Ventura, S., Zurdo, J., Narayanan, S., Parreño, M., Mangues, R., Reif, B., Chiti, F., Giannoni, E., Dobson, C. M., & Serrano, L. (2004). Short amino acid stretches can mediate amyloid formation in globular proteins: The Src homology 3 (SH3) case. Proceedings of the National Academy of Sciences, 101(19), 7258–7263. Cited by: 301

Rami Ahmad | Cancer Therapy | Best Researcher Award

Published on by Oncology

Prof. Dr. Rami Ahmad | Cancer Therapy | Best Researcher Award

Senior Researcher | Czech Education and Scientific Network | Czech Republic

Prof. Dr. Rami Ahmad El-Nabulsi is a distinguished theoretical physicist and applied mathematician whose research bridges nonlinear quantum dynamics, fractal mechanics, plasma and solid-state physics, and advanced mathematical modeling. Holding a PhD in Particle and Mathematical Physics from AMU, along with postgraduate diplomas in Plasma Physics and degrees in Physics at both master’s and bachelor’s levels, he has built a prolific career combining theoretical rigor with computational innovation. He is currently affiliated with the Center of Excellence in Quantum Technology, Faculty of Engineering, and the Quantum-Atom Optics Laboratory at Chiang Mai University, Thailand, as well as with the University of South Bohemia and the Department of Optical Networks CESNET in the Czech Republic. Prof. El-Nabulsi’s research interests encompass geometrical and quantum dynamics, nonlinear systems, chaos and bifurcations, general relativity, quantum field theory, and the application of fractional and fractal calculus to complex systems in engineering, astrophysics, and materials science. His expertise extends to advanced computational modeling, partial differential equations, stochastic systems, and numerical simulations. He has received multiple international honors, including the Outstanding Scientist Research Award and the Lifetime Achievement Award. A reviewer for more than 250 scientific journals and an editorial board member in over 40 peer-reviewed publications, he has authored more than 390 research articles in high-impact international journals and is frequently invited as an honorary speaker at global conferences. Prof. El-Nabulsi’s academic dedication, multidisciplinary approach, and sustained research excellence continue to shape theoretical and applied physics worldwide. His scholarly impact is reflected in 4,873 citations, 277 documents, and an h-index of 35, underscoring his influential role in advancing modern fractal physics and nonlinear dynamical systems research.

Profiles: Google Scholar | Scopus | ORCID 

Featured Publications

1. El-Nabulsi, R. A., & Anukool, W. (2025). Chaotic and fractal maps in higher-order derivative dynamical systems. Frontiers in Physics, 12, 1529644. Cited by: 8

2. El-Nabulsi, R. A., & Anukool, W. (2025). Qualitative financial modelling in fractal dimensions. Financial Innovation, 11, 42. Cited by: 6

3. El-Nabulsi, R. A. (2025). A fractional model to study soliton in presence of charged space debris at low-Earth orbital plasma region. IEEE Transactions on Plasma Science, 52(9), 4671–4693. Cited by: 4

4. El-Nabulsi, R. A., & Golmankhaneh, A. K. (2025). Propagation of waves in fractal spaces. Waves in Random and Complex Media. Cited by: 4

5. El-Nabulsi, R. A., & Anukool, W. (2025). Vlasov equation, waves and dispersion relations in fractal dimensions: Landau damping and the toroidal ion temperature gradient instability problem. Waves in Random and Complex Media. Cited by: 14

6. El-Nabulsi, R. A. (2024). Transition from circular to spiral waves and from Mexican hat to upside-down Mexican hat-solutions: The cases of local and nonlocal λ–ω reaction–diffusion–convection fractal systems with variable coefficients. Chaos, Solitons & Fractals, 189, 115737. Cited by: 3

7. El-Nabulsi, R. A. (2024). Modelling nematic liquid crystal in fractal dimensions. Medicine in Novel Technology and Devices, 24, 100334. Cited by: 7

Dr. Yaqin Wu | Carcinoma | Women Researcher Award

Published on by Oncology

Dr. Yaqin Wu | Carcinoma | Women Researcher Award

Hunan provincial people’s hospital | China

AUTHOR PROFILE

Scopus

🌟Wu Yaqin 

🏥CURRENT ROLES AND AFFILIATIONS 

  • Current Position: Organizational Committee Member, Graduate Student Party Branch
  • Graduate Institution: Hunan Provincial People’s Hospital (Hunan Normal University First Affiliated Hospital), Breast and Thyroid Surgery, Master’s Supervisor: Professor Zhang Chaojie
  • Undergraduate Institution: Hunan Normal University Medical School, Clinical Medicine (2014.9–2019.6)

📚EARLY ACADEMIC PURSUITS 

Wu Yaqin began her academic journey at Hunan Normal University Medical School, excelling in Clinical Medicine. Her undergraduate years were marked by stellar academic performance, with scholarships awarded every year, including National Scholarship and National Inspirational Scholarship.

🔬PROFESSIONAL ENDEAVORS 

Currently pursuing a Master’s degree in Surgery (Breast and Thyroid Surgery) at Hunan Provincial People’s Hospital, Wu has honed her clinical and research skills. She has gained recognition for:

  1. Outstanding clinical rotation performance.
  2. Active participation in surgeries, assisting in level 3 and 4 operations.
  3. Representing her hospital in Clinical Skills Competitions.

🧪CONTRIBUTIONS AND RESEARCH FOCUS 

Wu Yaqin has a strong foundation in research and innovation, focusing on:

  • Scientific Techniques: Proficiency in WB, PCR, single-cell sequencing, metabolomics, and other experimental skills.
  • Data Analysis: Skilled in SPSS, bioinformatics, and advanced statistical analysis.
  • Publications:
    • 2 SCI papers as the first and corresponding author (Cumulative Impact Factor: 5.143).
    • 2 core journal publications in China.
  • Research Projects:
    • Contributed to two provincial-level projects and two horizontal projects as the lead researcher (under mentor guidance).

🌟IMPACT AND INFLUENCE 

Wu’s contributions extend beyond academia:

  • Regularly earns recognition as an Outstanding Party Member, Student, and Graduate.
  • Actively involved in expert consensus compilation, adding to professional guidelines.
  • Participates in large-scale event organization with exceptional planning and execution skills.

PERSONAL SKILLS AND INTERESTS 🎙️

  • Language Proficiency:
    • Passed CET-4 and CET-6.
    • Achieved Grade 2-A in the National Mandarin Test.
  • Technical Skills:
    • Proficient in basic and advanced experimental techniques.
    • Skilled in computer applications (provincial-level certification).
  • Special Interests: Broadcasting, hosting, debate, and recitation.

RECOGNITION AND HONORS 🏅

During Master’s Program:

  • Authored high-impact research papers.
  • Contributed to prestigious projects and received multiple awards for academic excellence.

During Undergraduate Program:

  • Awarded numerous scholarships and honors.
  • Served in various leadership roles:
    • Vice Minister, Learning Department of the Student Union.
    • Captain, Debate Team.
    • Psychological Committee Member, Class Representative.

LEGACY AND FUTURE CONTRIBUTIONS 🌐

Wu Yaqin’s dedication to clinical excellence, innovative research, and effective communication positions her as a rising star in medical sciences. She is committed to:

  1. Advancing clinical practice and surgical expertise.
  2. Expanding her impact through cutting-edge research and mentorship roles.
  3. Building a legacy of leadership and service within the medical community.

 

📊🔬NOTABLE PUBLICATION:
  • 1. LncRNA SNHG5 promotes the glycolysis and proliferation of breast cancer cell through regulating BACH1 via targeting miR-299
    • Authors: Huang, S.-L., Huang, Z.-C., Zhang, C.-J., Wu, Y.-Q., Fan, P.-Z.
    • Journal: Breast Cancer
    • Year: 2022

    2. The expression and meaning of CD68, CD163, CD57, and IgG4 in granulomatous lobular mastitis

    • Authors: Kong, C., Zhang, C., Wu, Y., He, J., Fan, P.
    • Journal: Gland Surgery
    • Year: 2020

    3. miRNA-195-5p/PSAT1 feedback loop in human triple-negative breast cancer cells

    • Authors: Wang, H., Fang, Q., You, S., Wu, Y., Zhang, C.
    • Journal: Genes and Genomics
    • Year: 2023

    4. Value of dissection of lymph nodes posterior to the right recurrent laryngeal nerve in patients with cN0 papillary thyroid carcinoma

    • Authors: Xiao, X., Wu, Y., Zou, L., Chen, Y., Zhang, C.
    • Journal: Gland Surgery
    • Year: 2022

    5. A clinical observation of stage I implant breast reconstruction for mass-like granulomatous lobular mastitis

    • Authors: Zhang, C., Wu, Y., Wang, H., Li, Q., Fan, P.
    • Journal: Gland Surgery
    • Year: 2021

Dr. Zvi Perry | Breast Surgery | Best Researcher Award

Published on by Oncology

Dr. Zvi Perry | Breast Surgery | Best Researcher Award

Soroka University Medical Center | Israel

AUTHOR PROFILE

Scopus

ORCID ID

Google Scholar

DR. ZVI PERRY, SOROKA UNIVERSITY MEDICAL CENTER, MRI AND BREAST SURGERY, ISRAEL

🎓EARLY ACADEMIC PURSUITS 

Dr. Zvi Perry began his academic journey with a solid foundation in medicine, specializing in surgical disciplines. He pursued his medical education in Israel, where he demonstrated an early interest in the field of breast surgery. His commitment to learning and research was evident from the start, leading him to focus on innovative approaches in breast surgery and medical imaging, particularly in the use of MRI technology for diagnosis and treatment planning.

💼PROFESSIONAL ENDEAVORS 

Dr. Perry’s professional career is marked by his significant contributions to Soroka University Medical Center, where he has served as a leading figure in the Department of Surgery. His expertise in breast surgery has been a cornerstone of his work, and he has been instrumental in integrating advanced MRI techniques into surgical practices. His dedication to patient care and surgical precision has earned him a reputation as one of Israel’s foremost breast surgeons.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON BREAST SURGERY

Dr. Perry’s research focuses on the intersection of breast surgery and MRI technology. He has conducted pioneering studies on the use of MRI in the early detection and treatment of breast cancer, enhancing the accuracy of surgical interventions. His research has contributed to the development of less invasive surgical techniques, improving outcomes for patients. Dr. Perry’s work also extends to the study of post-surgical recovery and the long-term effects of breast surgery on patients’ quality of life.

🌍IMPACT AND INFLUENCE 

Dr. Perry’s influence extends beyond the walls of Soroka University Medical Center. He has been an active participant in national and international conferences, where he has shared his insights on breast surgery and MRI applications. His work has influenced surgical practices in Israel and around the world, contributing to the global advancement of breast cancer treatment. Dr. Perry is also involved in mentoring young surgeons, passing on his knowledge and skills to the next generation.

📚ACADEMIC CITES AND PUBLICATIONS 

Dr. Perry has published extensively in leading medical journals, with numerous articles cited by his peers in the fields of breast surgery and medical imaging. His work is frequently referenced in studies related to breast cancer diagnosis, MRI applications, and surgical innovations. These citations underscore the importance of his contributions to the medical community and highlight his role as a thought leader in his field.

🌟LEGACY AND FUTURE CONTRIBUTIONS 

Dr. Perry’s legacy is defined by his commitment to improving breast cancer treatment through surgical excellence and innovative research. His ongoing work in MRI technology continues to push the boundaries of what is possible in breast surgery. As he looks to the future, Dr. Perry is focused on further refining surgical techniques and expanding the use of MRI in other areas of surgery. His contributions will undoubtedly continue to shape the future of breast cancer treatment, leaving a lasting impact on both patients and the medical community.

💡OTHER IMPORTANT TOPICS 

In addition to his primary research and clinical work, Dr. Perry is also involved in educational initiatives aimed at raising awareness about breast cancer and the importance of early detection. He collaborates with various organizations to promote health education and support breast cancer patients throughout their treatment journey. Dr. Perry’s holistic approach to medicine, combining cutting-edge technology with compassionate care, exemplifies his dedication to advancing healthcare in Israel and beyond.

🎯CONCLUSION 

Dr. Zvi Perry’s career at Soroka University Medical Center is a testament to his unwavering dedication to advancing breast surgery through the innovative use of MRI technology. His early academic pursuits laid a strong foundation for a professional journey marked by groundbreaking research, impactful contributions, and a deep commitment to patient care. Dr. Perry’s influence extends globally, with his work shaping the future of breast cancer treatment and surgical practices. As a mentor, researcher, and surgeon, his legacy is one of excellence and innovation, ensuring that his contributions will continue to benefit the medical community and patients for years to come. 🌟

 

📊🔬NOTABLE PUBLICATION:

 

    • Title: Laparoscopic Sleeve Gastrectomy Following Failed Laparoscopic Adjustable Gastric Banding—a Comparison Between One- and Two-Stage Procedures, an Israeli National Database Study
      Authors: Perry, Z., Romano-Zelekha, O., Sakran, N., Netz, U., Kirshtein, B.
      Journal: Obesity Surgery
      Year: 2021

 

    • Title: Circulating Cell-free DNA in Patients with Acute Biliary Pancreatitis: Association with Disease Markers and Prolonged Hospitalization Time A Prospective Cohort Study
      Authors: Gibor, U., Perry, Z., Netz, U., Sebbag, G., Douvdevani, A.
      Journal: Annals of Surgery
      Year: 2022

 

    • Title: A Comparison of One- and Two-Stage Laparoscopic Sleeve Gastrectomy Following Failed Laparoscopic Adjustable Gastric Banding Using the BAROS Score
      Authors: Perry, Z.H., Zioni, T., Netz, U., Chorny, A., Kirshtein, B.
      Journal: Obesity Surgery
      Year: 2022

 

    • Title: Banded One-Anastomosis Gastric Bypass (BOAGB) for Patients Living with Obesity and Extreme Obesity: A Single Institution’s Experience
      Authors: Quint, E., Perry, Z.H., Elkrinawi, N., Sebbag, G., Dukhno, O.
      Journal: Obesity Surgery
      Year: 2024

 

    • Title: Gender Comparisons of Surgical Outcomes in Patients Undergoing One Anastomosis Gastric Bypass (OAGB): a Historical Cohort Study
      Authors: Abu-Zeid, E., Atias, S., Netz, U., Avital, I., Perry, Z.H.
      Journal: Obesity Surgery
      Year: 2024

Assoc Prof Dr.Marwa Muhammad Abu-Serie Ali – Targeted Cancer Therapy – Best Researcher Award

Published on by Oncology

Assoc Prof Dr.Marwa Muhammad Abu-Serie Ali - Targeted Cancer Therapy - Best Researcher Award

SRTA city - Egypt

AUTHOR PROFILE

Scopus

EARLY ACADEMIC PURSUITS:

Marwa Muhammad Abu-Serie Ali initiated her academic journey in the field of biochemistry, obtaining a Bachelor's degree from Alexandria University, Egypt, with honors. She continued her academic pursuits with a Master's degree in Biochemistry from the same university in 2008. Later, in 2014, Marwa achieved a significant milestone by completing her Ph.D. in the Biochemistry Department at the Faculty of Science, Alexandria University, Egypt. Her doctoral thesis focused on a model for drug assessment of colon cancer induced in murine cells.

PROFESSIONAL ENDEAVORS:

Marwa's professional journey encompasses various roles, starting from a Delegated Demonstrator at Alexandria University to her current position as an Associate Professor in the Medical Biotechnology Department at the Genetic Engineering and Biotechnology Research Institute (GEBRI) in Egypt. She has consistently contributed to research and academia, progressing from Assistant Researcher to Researcher and eventually to her current leadership position as an Associate Professor.

CONTRIBUTIONS AND RESEARCH FOCUS ON TARGETED CANCER THERAPY

Marwa's research focus is on medical biotechnology, with specific interests in tageted cancer therapy studies. Her work includes projects such as the assessment of nanotherapeutic approaches in colon cancer, the development of anti-coronavirus agents, and the evaluation of novel anticancer agents. She has also explored the anti-tumor efficacy of various formulations against different types of carcinoma, emphasizing a comprehensive and innovative approach to cancer treatment.

IMPACT AND INFLUENCE:

Marwa has made significant contributions to the scientific community through her involvement in research projects funded by prestigious organizations like the Science & Technology Development Fund (STDF), Fulbright, and the Academy of Scientific Research and Technology Center (STC). Her work has not only expanded scientific knowledge but has also paved the way for potential breakthroughs in cancer treatment and the fight against infectious diseases.

ACADEMIC CITATIONS:

Marwa's academic work has likely garnered citations in various research publications, reflecting the impact of her contributions to the field of medical biotechnology. These citations signify the acknowledgment and recognition of her research by peers and fellow scientists.

LEGACY AND FUTURE CONTRIBUTIONS:

Marwa's legacy lies in her commitment to advancing knowledge in medical biotechnology, particularly in cancer research and antiviral drug development. Her future contributions are anticipated to further shape the landscape of biomedical research, potentially leading to breakthroughs in cancer treatment and viral therapeutics.

NOTABLE PUBLICATIONS

Anticancer activity of lactoferrin-coated biosynthesized selenium nanoparticles for combating different human cancer cells via mediating apoptotic effects.2023

Inhibitory effect of lactoferrin-coated zinc nanoparticles on SARS-CoV-2 replication and entry along with improvement of lung fibrosis induced in adult male albino rats.2023

Concurrent Tissue Engineering for Wound Healing in Diabetic Rats Utilizing Dual Actions of Green Synthesized CuO NPs Prepared from Two Plants Grown in Egypt.2023